Gene Therapy Co. Xenon Pharma Misses Target In $36M IPO
Xenon Pharmaceuticals Inc. on Tuesday raised $36 million in its initial public offering, pricing below its intended range and missing its target by at least $4 million, showing that October's uncertainty...To view the full article, register now.
Already a subscriber? Click here to view full article